Courtney Andersen studies the role of estrogen receptor-alpha in ovarian cancer.
Chris Barnes investigates the structural details by which transcription factor activity regulates RNA Polymerase II during the universal process of eukaryotic gene expression.
Soma Jobaggy studies nitrated fatty acid pharmacology and the antioxidant response in hypertensive end-organ damage.
Allison Nagle studies growth factor receptor signaling in breast cancer.
Peter Wipf, PhD
University Professor of Chemistry
1301 Chevron Hall
Pittsburgh, PA 15261

Phone: 412-624-8606

Fax: 412-624-0787

BS (Chemistry), University of Zurich, 1984.
PhD (Chemistry), University of Zurich, 1987.
Postdoctoral Fellow, University of Virginia, 1988-90

Research Areas
Drug Discovery
Photo of Peter Wipf, PhD

Dr. Wipf’s research focuses on Total Synthesis of Natural Products - the development of new methodology, mechanistic and physical organic experiments, conformational and configurational analysis by spectroscopic and computational methods, and bio-organic and medicinal chemistry.

Organometallic Chemistry will provide most of the new revolutionary techniques for C, C and C-heteroatom bond formations and asymmetic catalysis. Dr. Wipf’s group has had a long tradition in synthetic applications of transition metals. Recently they developed the first general protocol for alkene-alkyne hetero-couplings.

His lab also is interested in the development of new stereoselctive methods for the preparation of highly functionalized heterocycles. In particular, they have developed novel protocols for five-membered heterocycle synthesis that have been widely adopted in industry and academe. Research is also conducted on Combinatorial and Solid Phase Synthesis, and Computational Prediction of Macroscopic Properties.


No other events in the next seven days. Check the Department Event Calendar for more upcoming events. Pharmacology and Chemical Biology Event Calendar

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings

Outcomes:  Time to disseration, last five graduating classes:  4.5 years, Completion Rate: 84.8%

Ranked #9 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty four consecutive years

Back to Top